Ipsen News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.05.16	Oncodesign and Ipsen Enter into a Strategic Partnership in Oncology and Oncodesign Joins Ipsen’s Paris-Saclay Campus (Businesswire)
28.04.16	Ipsen’s First Quarter 2016 Sales (Businesswire)
26.04.16	Probi and Ipsen Sign Extensive Primary Care Distribution Agreement for Probiotic LP299V®, Lactobacillus plantarum 299v (Businesswire)
08.04.16	Ipsen: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
05.04.16	Dassault Systèmes and Ipsen sign collaborative agreement to develop innovative programs to support Ipsen’s drug discovery (Businesswire)
31.03.16	The Ipsen Group Publishes Its 2015 Registration Document (Businesswire)
07.03.16	Ipsen: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
07.03.16	Ipsen: Information Relating to the Compensation of Executive Directors (Businesswire)
01.03.16	Ipsen’s 2015 Results and 2016 Financial Objectives (Businesswire)
01.03.16	Exelixis and Ipsen Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Regions Outside the United States, Canada and Japan (Businesswire)
29.02.16	Exelixis and Ipsen Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Regions Outside the United States, Canada and Japan (Businesswire)
22.02.16	IPSEN: Information Relating to the Conditions of Termination of Mrs. Christel Bories' Corporate Duties (Businesswire)
16.02.16	Changes to Ipsen Corporate Governance (Businesswire)
08.02.16	Ipsen: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
08.01.16	Ipsen: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
06.01.16	Half-Year IPSEN Liquidity Contract Statement Entered into With NATIXIS (Businesswire)
06.01.16	Ipsen and Galderma Expand Current Distribution Agreement for Dysport® in Aesthetic Indications to Some Key Asia-Pacific Territories1 (Businesswire)
04.01.16	IPSEN: Disclosure of Transactions in Own Shares on 28/12/2015 (Businesswire)
04.01.16	Ipsen: Disclosure of Transactions in Own Shares Between 21/12/2015 and 24/12/2015 (Businesswire)
22.12.15	IPSEN: Disclosure of Transactions in Own Shares between 14/12/2015 and 18/12/2015 (Businesswire)
17.12.15	Ipsen Announces Its Corporate Agenda for 2016 (Businesswire)
15.12.15	Ipsen: Disclosure of Transactions in Own Shares between 07/12/2015 and 11/12/2015 (Businesswire)
08.12.15	Ipsen: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
07.12.15	IPSEN: Disclosure of Transactions in Own Shares between 30/11/2015 and 04/12/2015 (Businesswire)
30.11.15	IPSEN: Disclosure of transactions in own shares between 23/11/2015 and 27/11/2015 (Businesswire)
23.11.15	IPSEN: Disclosure of transactions in own shares between 16/11/2015 and 20/11/2015 (Businesswire)
19.11.15	Ipsen and Interprotein enter into a research collaboration for novel peptides in endocrinology (Businesswire)
16.11.15	IPSEN: Disclosure of transactions in own shares between 09/11/2015 and 13/11/2015 (Businesswire)
09.11.15	IPSEN: Disclosure of transactions in own shares between 02/11/2015 and 06/11/2015 (Businesswire)
06.11.15	Ipsen: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
02.11.15	IPSEN: Disclosure of Transactions in Own Shares between 26/10/2015 and 30/10/2015 (Businesswire)
29.10.15	Ipsen: sales in the 3rd quarter and first nine months of 2015 (Businesswire)
28.10.15	Telesta Therapeutics and Ipsen Announce Exclusive License Agreement for MCNA1 for the Treatment of Non-Muscle Invasive Bladder Cancer in Major Ex-United States Territories (Businesswire)
26.10.15	IPSEN: Disclosure of Transactions in Own Shares between 19/10/2015 and 23/10/2015 (Businesswire)
26.10.15	Ipsen and EpiVax collaborate to produce next generation botulinum toxins (Businesswire)
19.10.15	IPSEN: Disclosure of Transactions in Own Shares Between 12/10/2015 and 16/10/2015 (Businesswire)
12.10.15	IPSEN: Disclosure of Transactions in Own Shares Between 05/10/2015 and 09/10/2015 (Businesswire)
08.10.15	IPSEN S.A.: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
05.10.15	IPSEN: Disclosure of Transactions in Own Shares between 28/09/2015 and 02/10/2015 (Businesswire)
01.10.15	Stéphane Bessette is appointed Executive Vice President, Human Resources of Ipsen (Businesswire)
01.10.15	Ipsen Announces Release of an Additional Batch of Increlex® in the U.S. (Businesswire)
28.09.15	IPSEN: Disclosure of Transactions in Own Shares Between 21/09/2015 and 25/09/2015 (Businesswire)
21.09.15	IPSEN: Disclosure of transactions in own shares between 14/09/2015 and 18/09/2015 (Businesswire)
14.09.15	IPSEN: Disclosure of Transactions in Own Shares between 07/09/2015 and 11/09/2015 (Businesswire)
10.09.15	Ipsen: Monthly information regarding the total number of voting rights and total number of shares of the Company (Businesswire)
07.09.15	IPSEN: Disclosure of transactions in own shares between 31/08/2015 and 04/09/2015 (Businesswire)
31.08.15	IPSEN: Disclosure of Transactions in Own Shares Between 24/08/2015 and 28/08/2015 (Businesswire)
24.08.15	IPSEN : Disclosure of Transactions in Own Shares between 17/08/2015 and 21/08/2015 (Businesswire)
14.08.15	IPSEN: Disclosure of Transactions in Own Shares Between 10/08/2015 and 14/08/2015 (Businesswire)
10.08.15	IPSEN: Disclosure of Transactions in Own Shares Between 03/08/2015 and 07/08/2015 (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	536.40	1.02 %	K V
Part Grp Hldg	1’255.50	0.36 %	K V
Roche Hldg G	252.30	0.36 %	K V
Novartis	92.18	0.27 %	K V
Alcon	77.78	0.21 %	K V
CieFinRichemont	121.60	-0.61 %	K V
ABB	49.21	-0.67 %	K V
UBS Group	27.51	-0.90 %	K V
Sika	226.10	-1.09 %	K V
Logitech Intl	70.48	-2.08 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Ipsen

Aktien Top/Flop

Meistgelesene Nachrichten